Pre-clinical (animal) studies have found that Molnupiravir has remarkably reduced SARS-CoV-2 load and was found to have completely suppress...

The Phase-II study of the vaccine, ZyCoV-D, had been conducted in over 1,000 healthy adult volunteers as part of the adaptive Phase-I and I...

Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical...

The Zydus family comprising 25,000 Zydans stands committed to the 'Aatmanirbhar Bharat' mission and offering the nation safe and efficaciou...

Serum Institute of India (SII) and ICMR have partnered for clinical development of two global vaccine candidates.

"The company reports that the doses of the vaccine administered to healthy volunteers in the phase I clinical trial, which began on July 15...

At a recent meeting at the Central Drugs Standard Control Organisation (CDSCO)-the regulatory authority of India, subject experts recommend...

Sensex gained 479 points to 38,623 while Nifty added 170 points to close at 11,303.

iClinic, which has a clutch of investors besides Mukerji and Berry, was set up in 2012 with the business model of offering healthcare to pe...

Technology-enabled models, like iClinic & iKure, are emerging in India which are addressing lack of healthcare facilities in underserved re...

Berry has been tightening left, right and centre. He’s been nudging sales managers to step out of office and engage more with trade partner...

“Unlike MNCs which have pre-defined roles, the challenges, the sense of ownership and the work culture in a start-up is more fulfilling."

Berry has flung himself at this job with characteristic gusto. "I am a dreamer," he says. "When I fail, at times, to achieve those dreams, ...

Queppelin is attempting to be the mobile application partner and consultant to enterprises large and small.

Piramal Healthcare today said it has completed the first phase of clinical trials of a new oral drug for treating cancer and will move to t...

Piramal Life Sciences, the listed research and development (R&D) subsidiary of Piramal Healthcare, is hoping to hit the market with its fir...

Onkar Kanwar, the chairman of 260-bed multi-specialty Gurgaon hospital of Artemis Health Sciences, shares the company's plans with ET.